Experts Warn EU, U.S. Companies to Secure Chinese Supply Chain

International Pharmaceutical Regulatory Monitor
A A
U.S. and European pharma companies “are misinformed about the identity of manufacturers involved in all or part of the supply chain of 39 percent of drug substances they purchase from China,” an industry expert says.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00